The project „COVIDRUGS“ funded by Slovak Agency for Science and Research has been successfully finalized on 31. December 2021

ICARST, through its joint laboratory with University of SS. Cyril and Methodius (ICARST - UCM) has contributed to the results of the project. The project brought original results in a coordinated study of five partner laboratories specializing in computer-assisted drug design, bioavailability studies, drug synthesis, enzymatic and in vitro testing of biological activity of new substances that inhibit coronavirus viral enzymes, as well as SARS-CoV-2 virus replication in vitro in infected human cell lines.